The role of ion channels in malignant brain tumors

Journal of Neuro-Oncology

Volumn 125, Issue 2, 2015, Pages 225-235

  Simon, Ole J ^a   Müntefering, Thomas ^a   Grauer, Oliver M ^a   Meuth, Sven G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Brain tumor; Ion channels; Malignant glioma; Tumor cells

Indexed keywords

5 NITRO 2 (3 PHENYLPROPYLAMINO)BENZOIC ACID; AQUAPORIN 1; AQUAPORIN 8; BUMETANIDE; CALCIUM CHANNEL; CALCIUM ION; CHLORIDE CHANNEL; CHLORIDE ION; POTASSIUM CHANNEL; POTASSIUM ION; SODIUM CHANNEL; SODIUM ION; TAMOXIFEN; TEMOZOLOMIDE; ION CHANNEL;

ANTINEOPLASTIC ACTIVITY; ASTROCYTE; ASTROCYTOMA; BRAIN CANCER; CANCER GRADING; CANCER INHIBITION; DRUG SENSITIVITY; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; MOLECULARLY TARGETED THERAPY; NEUROPATHOLOGY; PROTEIN EXPRESSION; REVIEW; BRAIN TUMOR; GENETICS; METABOLISM; PATHOLOGY;

BRAIN NEOPLASMS; HUMANS; ION CHANNELS;

EID: 84945473690     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-015-1896-9     Document Type: Review

References (62)

1. Becchetti A (2011) Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. Am J Physiol Cell Physiol 301:C255–C265
2. Soroceanu L, Manning TJ Jr, Sontheimer H (1999) Modulation of glioma cell migration and invasion using Cl(−) and K(+) ion channel blockers. J Neurosci 19:5942–5954
3. Prevarskaya N, Skryma R, Shuba Y (2010) Ion channels and the hallmarks of cancer. Trends Mol Med 16:107–121
4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109
5. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466
6. von Deimling A, Louis DN, Wiestler OD (1995) Molecular pathways in the formation of gliomas. Glia 15:328–338
7. Louis DN (1994) The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 53:11–21
8. Ye ZC, Rothstein JD, Sontheimer H (1999) Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci 19:10767–10777
9. Ye ZC, Sontheimer H (1999) Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59:4383–4391
10. Nakada M, Okada Y, Yamashita J (2003) The role of matrix metalloproteinases in glioma invasion. Front Biosci 8:e261–e269
11. Bordey A, Sontheimer H (2000) Ion channel expression by astrocytes in situ: comparison of different CNS regions. Glia 30:27–38
12. +-ATPase activity in cultured mouse neurons and astrocytes. Neurochem Int 28:335–342
13. Charles AC, Merrill JE, Dirksen ER, Sanderson MJ (1991) Intercellular signaling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate. Neuron 6:983–992
14. Shigetomi E, Bowser DN, Sofroniew MV, Khakh BS (2008) Two forms of astrocyte calcium excitability have distinct effects on NMDA receptor-mediated slow inward currents in pyramidal neurons. J Neurosci 28:6659–6663
15. Nedergaard M, Ransom B, Goldman SA (2003) New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26:523–530
16. Simard M, Nedergaard M (2004) The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129:877–896
17. Pasantes-Morales H, Cardin V, Tuz K (2000) Signaling events during swelling and regulatory volume decrease. Neurochem Res 25:1301–1314
18. Halassa MM, Fellin T, Haydon PG (2009) Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 57:343–346
19. Smits A, Jin Z, Elsir T, Pedder H, Nister M, Alafuzoff I, Dimberg A, Edqvist PH, Ponten F, Aronica E, Birnir B (2012) GABA-A channel subunit expression in human glioma correlates with tumor histology and clinical outcome. PLoS One 7:e37041
20. Garzon-Muvdi T, Schiapparelli P, ap Rhys C, Guerrero-Cazares H, Smith C, Kim DH, Kone L, Farber H, Lee DY, An SS, Levchenko A, Quinones-Hinojosa A (2012) Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation. PLoS Biol 10:e1001320
21. Arvind S, Arivazhagan A, Santosh V, Chandramouli BA (2012) Differential expression of a novel voltage gated potassium channel–Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma. Br J Neurosurg 26:16–20
22. Bielanska J, Hernandez-Losa J, Perez-Verdaguer M, Moline T, Somoza R, Ramon YCS, Condom E, Ferreres JC, Felipe A (2009) Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer. Curr Cancer Drug Targets 9:904–914
23. Basrai D, Kraft R, Bollensdorff C, Liebmann L, Benndorf K, Patt S (2002) BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells. NeuroReport 13:403–407
24. + channel in malignant astrocytoma cell lines. J Neurosci Res 48:122–127
25. Bordey A, Sontheimer H (1998) Electrophysiological properties of human astrocytic tumor cells In situ: enigma of spiking glial cells. J Neurophysiol 79:2782–2793
26. Kraft R, Basrai D, Benndorf K, Patt S (2001) Serum deprivation and NGF induce and modulate voltage-gated Na(+) currents in human astrocytoma cell lines. Glia 34:59–67
27. + conductance. Am J Physiol 276:C1405–C1410
28. Schrey M, Codina C, Kraft R, Beetz C, Kalff R, Wolfl S, Patt S (2002) Molecular characterization of voltage-gated sodium channels in human gliomas. NeuroReport 13:2493–2498
29. Xing D, Wang J, Ou S, Wang Y, Qiu B, Ding D, Guo F, Gao Q (2014) Expression of neonatal Nav1.5 in human brain astrocytoma and its effect on proliferation, invasion and apoptosis of astrocytoma cells. Oncol Rep 31:2692–2700
30. Yang M, Kozminski DJ, Wold LA, Modak R, Calhoun JD, Isom LL, Brackenbury WJ (2012) Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer. Breast Cancer Res Treat 134(2):603–615
31. Olsen ML, Schade S, Lyons SA, Amaral MD, Sontheimer H (2003) Expression of voltage-gated chloride channels in human glioma cells. J Neurosci 23:5572–5582
32. Lui VC, Lung SS, Pu JK, Hung KN, Leung GK (2010) Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3. Anticancer Res 30:4515–4524
33. Su J, Xu Y, Zhou L, Yu HM, Kang JS, Liu N, Quan CS, Sun LK (2013) Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy. Anat Rec 296:595–603
34. Algharabil J, Kintner DB, Wang Q, Begum G, Clark PA, Yang SS, Lin SH, Kahle KT, Kuo JS, Sun D (2012) Inhibition of Na(+)-K(+)-2Cl(−) cotransporter isoform 1 accelerates temozolomide-mediated apoptosis in glioblastoma cancer cells. Cell Physiol Biochem 30:33–48
35. Gagnon KB (2012) High-grade glioma motility reduced by genetic knockdown of KCC3. Cell Physiol Biochem 30:466–476
36. Olsen ML, Sontheimer H (2004) Mislocalization of Kir channels in malignant glia. Glia 46:63–73
37. MacFarlane SN, Sontheimer H (2000) Changes in ion channel expression accompany cell cycle progression of spinal cord astrocytes. Glia 30:39–48
38. Tan G, Sun SQ, Yuan DL (2008) Expression of Kir 4.1 in human astrocytic tumors: correlation with pathologic grade. Biochem Biophys Res Commun 367:743–747
39. Ransom CB, Sontheimer H (2001) BK channels in human glioma cells. J Neurophysiol 85:790–803
40. + channel isoforms from human brain. Neuron 13:1315–1330
41. Ransom CB, Liu X, Sontheimer H (2002) BK channels in human glioma cells have enhanced calcium sensitivity. Glia 38:281–291
42. Liu X, Chang Y, Reinhart PH, Sontheimer H (2002) Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells. J Neurosci 22:1840–1849
43. Weaver AK, Liu X, Sontheimer H (2004) Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res 78:224–234
44. 2+, BK channel activity and cell migration. J Biomed Sci 16:90
45. Patt S, Preussat K, Beetz C, Kraft R, Schrey M, Kalff R, Schonherr K, Heinemann SH (2004) Expression of ether a go-go potassium channels in human gliomas. Neurosci Lett 368:249–253
46. Masi A, Becchetti A, Restano-Cassulini R, Polvani S, Hofmann G, Buccoliero AM, Paglierani M, Pollo B, Taddei GL, Gallina P, Di Lorenzo N, Franceschetti S, Wanke E, Arcangeli A (2005) hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. Br J Cancer 93:781–792
47. D’Alessandro G, Catalano M, Sciaccaluga M, Chece G, Cipriani R, Rosito M, Grimaldi A, Lauro C, Cantore G, Santoro A, Fioretti B, Franciolini F, Wulff H, Limatola C (2013) KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo. Cell Death Dis 4:e773
48. Turner KL, Honasoge A, Robert SM, McFerrin MM, Sontheimer H (2014) A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma. Glia 62:971–981
49. Bittner S, Budde T, Wiendl H, Meuth SG (2010) From the background to the spotlight: TASK channels in pathological conditions. Brain Pathol 20:999–1009
50. + channels: role in apoptosis and tumorigenesis. Pflugers Arch 448:261–273
51. Meuth SG, Herrmann AM, Ip CW, Kanyshkova T, Bittner S, Weishaupt A, Budde T, Wiendl H (2008) The two-pore domain potassium channel TASK3 functionally impacts glioma cell death. J Neurooncol 87:263–270
52. 2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci 27:7987–8001
53. Zhang Y, Zhang J, Jiang D, Zhang D, Qian Z, Liu C, Tao J (2012) Inhibition of T-type Ca(2)(+) channels by endostatin attenuates human glioblastoma cell proliferation and migration. Br J Pharmacol 166:1247–1260
54. Ding X, He Z, Zhou K, Cheng J, Yao H, Lu D, Cai R, Jin Y, Dong B, Xu Y, Wang Y (2010) Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst 102:1052–1068
55. + channels contribute to regulatory volume increases in human glioma cells. Am J Physiol Cell Physiol 293(3):C1181–C1185
56. Joshi AD, Parsons DW, Velculescu VE, Riggins GJ (2011) Sodium ion channel mutations in glioblastoma patients correlate with shorter survival. Mol Cancer 10:17
57. Cuddapah VA, Turner KL, Seifert S, Sontheimer H (2013) Bradykinin-induced chemotaxis of human gliomas requires the activation of KCa3.1 and ClC-3. J Neurosci 33:1427–1440
58. Palani M, Arunkumar R, Janardhanam VAPD (2010) Biochemical and cytogenetic analysis of brain tissues in different grades of glioma patients. Ann Neurosci 17:120–125
59. Kislin KL, McDonough WS, Eschbacher JM, Armstrong BA, Berens ME (2009) NHERF-1: modulator of glioblastoma cell migration and invasion. Neoplasia 11:377–387
60. Zhu SJ, Wang KJ, Gan SW, Xu J, Xu SY, Sun SQ (2013) Expression of aquaporin8 in human astrocytomas: correlation with pathologic grade. Biochem Biophys Res Commun 440:168–172
61. El Hindy N, Bankfalvi A, Herring A, Adamzik M, Lambertz N, Zhu Y, Siffert W, Sure U, Sandalcioglu IE (2013) Correlation of aquaporin-1 water channel protein expression with tumor angiogenesis in human astrocytoma. Anticancer Res 33:609–613
62. Di Cristofori A, Carrabba G, Lanfranchi G, Menghetti C, Rampini P, Caroli M (2013) Continuous tamoxifen and dose-dense temozolomide in recurrent glioblastoma. Anticancer Res 33(8):3383–3389